Acorda reports fourth quarter net revenue of $133 Click to read more.
Acorda reports fourth quarter net revenue of $133.1 million for full year ended December 31, 2010 Acorda Therapeutics, Inc. Today announced its financial results for the fourth one fourth and full calendar year ended December 31, 2010 Click to read more . ‘In just its first ten months since launch, 40 approximately,000 people, or 10 percent of the MS inhabitants in the United States, received a prescription for AMPYRA. This displays the enormous medical need for a medication to improve walking in people who have MS, one of the most stressing and pervasive disabilities connected with this condition,’ said Ron Cohen, M.D., Acorda Therapeutics’ President and CEO.
Combined with the new content, Acsis in addition has produced a short video that helps businesses understand the necessity of cloud-centered data and process management.. Acsis addresses future and current requirements for global supply network Acsis Inc., the marketplace leader for source chain visibility, brand safety and serialization solutions, offers posted articles recently, Future of Working Your Business that addresses current and potential needs for companies' extended supply chain, today and explains how solutions for the old source chain model no longer work. The article clarifies how today's developments in technology, like the growth of mobile technology, machine to machine connectivity, and the web, have established a fresh global enterprise business design, and with having less centralized operations, companies fear losing control of their brand safety initiatives.